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Letters to the EditorAORTIC STENOSIS AND
STATINS
To the Editor:
The meta-analysis by Takagi and
coworkers1 addresses the effect of sta-
tins on aortic stenosis. The authors1254 The Journal of Thoracic anconclude that statins do retard the pro-
gression of aortic stenosis by retarding
the increase in peak aortic jet velocity
(PAJV) but not reducing the decrease
in aortic valve area (AVA). The recent
publication of the Simvastatin and
Ezetimibe in Aortic Stenosis (SEAS)
study2 prompted us to do a meta-
analysis on the same question to see
whether there is any difference in the
summary estimate. During this pro-
cess, we realized that there were
some errors in the calculation of the
summary estimate. In brief, the units
had been mixed in the calculations.
The data for AVA and PAJV for the
Bellamy3 and Mohler4 studies were ex-d Cardiovascular Surgery c November 2pressed as percentage change per year,
whereas for the rest of the studies, the
PAJV was in meters per second per
year, and for AVA, it was in square me-
ters per year. Itwas almost impossible to
create a Forrest plot with their data, and
the percentage data became huge and
far away from the rest of the studies,
which became almost invisible dots in
the figure. This must have prompted
the authors to use the standardized
mean difference in figures.
We corrected this mistake by projec-
ting the AVA and PAJV change per
year using the baseline values and per-
centage change data expressed in the
original articles (Figures 1 and 2).FIGURE 1. Annualized increase in peak aortic jet velocity (PAJV; mean difference).
FIGURE 2. Annualized decrease in aortic valve area (AVA; mean difference).009
in wound area per day (in square cen-
timeters), a change in wound area until
surgical closure (in square centime-
ters), and a relative change in wound
area until surgical closure or hospital
discharge (in percentages) were com-
bined by using the SMD method.
Although Vedamurthy and associates1
projected the AVA and PAJV change
per year by using the baseline values
and percentage change data expressed
in the original articles, precise calcula-
tion methods were not mentioned.
Was the mean of the absolute change
in the AVA or PAJV calculated by
multiplying the mean of the baseline
value by the mean of the percentage
change? It is mathematically obvious,
however, that the mean of the absolute
change is not equal to the product of
the mean of the baseline value by the
mean of the percentage change. Fur-
thermore, how was the standard devia-
tion (SD) of the change in the AVA or
PAJV? The SD of the absolute change
also cannot be equal to the product of
the mean of the baseline value by the
SD of the percentage change. We do
not have the slightest doubt that the
SMD method using the absolute and
percentage changes themselves ex-
pressed in the original article is better
Higgins JPT, Green S, editors. Cochrane Handbook
for Systematic Reviews of Interventions Version
5.0.1 (updated September 2008). The Cochrane
Collaboration, 2008. Available at: www.cochrane-
handbook.org.
4. Gregor S, Maegele M, Sauerland S, Krahn JF,
Peinemann F, Lange S. Negative pressure wound
therapy: a vacuum of evidence? Arch Surg. 2008;
143:189-96.
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TRANSCATHETER HEART
VALVE OPTIMAL SIZE
To the Editor:
We read with interest the comments
of Zegdi and colleagues1 on our
article entitled ‘‘Surgical aortic valve
replacement after percutaneous aortic
valve implantation: what have we
learned?’’2 The authors raised several
important questions about transcath-
eter heart valve (THV) size selection
according to the aortic annular diame-
ter and the issue of oversizing. In the
case reported a 23-mm balloon ex-
pandable Cribier–Edwards THV had
been selected for an aortic annulus
measured to 20 mm by using echocar-
diographic analysis (2 mm of oversiz-
ing), which was in agreement with the
Edwards company’s recommenda-
tions. After THV implantation, it
clearly appeared that the THV size
Letters to the EditorThus, we were able to calculate the
mean difference instead of the stan-
dardizedmean difference of the param-
eters of interest (PAJV and AVA).
Although our results are similar to
those of the original meta-analysis,
even after including the SEAS study,
we have enclosed the correct method-
ology to arrive at the conclusion.
Deepak Vedamurthy, MD
Janos Molnar
Rohit Arora, MD
Chicago Medical School
Chicago, III
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doi:10.1016/j.jtcvs.2009.07.050Reply to the Editor:
We appreciate the comments by
Vedamurthy and associates1 on our
meta-analysis.2 The standardized
mean difference (SMD) is used as
a summary statistic in meta-analyses
when the studies all assess the same
outcome but measure it in a variety
of ways (eg, all studies measure de-
pression, but they use different psy-
chometric scales).3 Vedamurthy and
colleagues stated that there were
some errors in the calculation of the
summary estimate: the units for aortic
valve area (AVA) and peak aortic jet
velocity (PAJV) had been mixed in
the calculations. Similar summary esti-
mates, however, can be commonly
found in published meta-analyses. In
a meta-analysis of negative pressure
wound therapy,4 for instance, a change
than the simple mean difference
method using the absolute changes
that are complexly calculated by
authors of a meta-analysis. However,
we would like to know how Vedamur-
thy and associates calculated the mean
or SD of the absolute change.
Hisato Takagi, MD, PhD
Takuya Umemoto, MD, PhD
Department of Cardiovascular
Surgery
Shizuoka Medical Center
Shizuoka, Japan
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was too small, explaining the subse-
quent severe paravalvular leak leading
to surgical valve replacement.
Retrospectively, it seems that
the transthoracic echocardiographic
(TTE) and transesophageal echocar-
diographic (TEE) measurements defi-
nitely underestimated the annular
diameter. A 26-mm THV size should
have been implanted in this patient,
as in any similarly tall male patient.
The lack of annular ring in the stented
THV device might explain the differ-
ence with the bioprosthesis size (23
mm) surgically implanted in this pa-
tient. The accuracy of annular size
echocardiographic measurement is
a technical issue, which has been
solved thereafter. This patient was
our second case included in the first
multicenter European Registry of En-
dovascular Implantation of Valves in
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